// App-Quantinova.ai

TCT-636 : Final Three Year Results Following Resolute Zotarolimus-Eluting Stent Implantation in the RESOLUTE International Trial

Researchers

Presenter

  • Franz-Josef Neumann

Principal Investigators

  • Petr Widimsky

  • Jorge Belardi

Medical Centers

  • Universitaets-Herzzentrum Freiburg Bad Krozingen, Bad Krozingen, Germany

  • Charles Univ and VFN, Prague, Czech Republic

  • Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina

Locations

  • Germany

  • Czech Republic

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Diabetes

  • Angina

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Clopidogrel bisulfate

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved